Second CAR t dose targets lymphoma relapse in High-Risk patients
NCT ID NCT05794958
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 28 times
Summary
This early-phase study tests whether a second infusion of the CAR T-cell therapy axicabtagene ciloleucel (Axi-Cel) is safe for adults with aggressive non-Hodgkin lymphoma who are at high risk of the cancer returning after their first standard CAR T treatment. About 20 participants will receive the second dose and be monitored for side effects and how long they stay cancer-free. The goal is to find a way to better control the disease in patients who face a high chance of relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGPalo Alto, California, 94305, United States
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.